Skip to main content
Log in

Topical NSAIDs for Musculoskeletal Conditions

A Review Of The Literature

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Abstract

In recent years a growing number of topical nonsteroidal anti-inflammatory drugs (NSAIDs) have become available. This has been prompted in large part by the high incidence of serious gastrointestinal adverse events associated with the use of systemic NSAIDs, and the premise that minimisation of plasma concentrations of active drug may result in fewer systemic adverse effects. Evidence in humans and animals with topical NSAIDs demonstrates lower plasma concentrations than with systemically administered drugs, while those in soft tissues are still of a magnitude considered consistent with exerting an anti-inflammatory effect. In joints, however, the evidence is less strong, and there is still dispute whether in this case the drug reaches the joint predominantly via the transcutaneous or systemic route.

There has been a sufficient number of studies of soft tissue conditions to demonstrate the superiority of topical NSAIDs over placebo and to suggest equivalent efficacy in comparison with some oral NSAIDs. For arthropathies, however, the literature is more sparse. Although several studies claim a benefit for topical NSAIDs against placebo, the results are less conclusive and further study is required. Trials of topical agents against intra-articular corticosteroids and rubefacients are either lacking or inconclusive. The adverse event profile of topical agents is reasonable: minor cutaneous effects occur in up to 2% of patients but tend to be self-limiting. Gastrointestinal events appear from the existing literature to be infrequent and minor, although long term studies are required. Bronchospasm and renal impairment have been reported and may be more frequent in patients who have experienced these effects with oral agents. The initial costs of topical agents tend to be higher than those of oral agents but a cost-effectiveness analysis suggests an overall benefit: this issue requires further clarification.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Johnson AG, Quinn DI, Day RO. Non-steroidal anti-inflammatory drugs. Med J Aust 1995; 163: 155–8

    PubMed  CAS  Google Scholar 

  2. Figueras A, Capeila D, Castel JM, et al. Spontaneous reporting of adverse drug reactions to non-steroidal anti-inflammatory drugs. Eur J Clin Pharmacol 1994; 47: 297–303

    Article  PubMed  CAS  Google Scholar 

  3. Lichtenstein DR, Syngal S, Wolfe MM. Nonsteroidal anti-inflammatory drags and the gastrointestinal tract. Arthritis Rheum 1995; 38: 5–18

    Article  PubMed  CAS  Google Scholar 

  4. Hansen TM, Matzen P, Madsen P. Endoscopie evaluation of the effect of indomethacin capsules and suppositories on the gastric mucosa in rheumatic patients. J Rheumatol 1984; 11: 484–7

    PubMed  CAS  Google Scholar 

  5. Jung TTK, Rhee C-K, Lee CS, et al. Ototoxicity of salicylate, non-steroidal anti-inflammatory drugs, and quinine. Otolaryngol Clin North Am 1993; 26: 791–810

    PubMed  CAS  Google Scholar 

  6. Brien JA. Ototoxicity associated with salicylates: a brief review. Drug Saf 1993; 9: 142–8

    Article  Google Scholar 

  7. Wynne HA, Rawlins MD. Are systemic levels of nonsteroidal anti-inflammatory drags relevant to acute upper gastrointestinal hemorrhage? Eur J Clin Pharmacol 1993; 44: 309–13

    Article  PubMed  CAS  Google Scholar 

  8. Brooks PM. NSAIDs. In: Klippel JH, Dieppe PA, editors. Rheumatology. London: Mosby, 1994. 8: 10: 1–8: 10: 6

    Google Scholar 

  9. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drags. Nature 1971; 231: 232–5

    CAS  Google Scholar 

  10. Vane J. Towards a better aspirin. Nature 1994; 367: 215–6

    Article  PubMed  CAS  Google Scholar 

  11. Brooks PM, Kean WF, Buchanan WW, editors. The clinical pharmacology of anti-inflammatory agents. Philadelphia: Taylor & Francis, 1986

    Google Scholar 

  12. Paulus HE, Bulpitt KJ. Nonsteroidal anti-inflammatory agents and corticosteroids. In: Schumacher HR, Klippel JH, Koopman WJ, editors. Primer on the rheumatic diseases. 10th ed. Atlanta: Arthritis Foundation, 1993

    Google Scholar 

  13. Insel PA. Analgesic-antipyretics and anti-inflammatory agents: drugs employed in the treatment of rheumatoid arthritis and gout. In: Goodman Gilman A, Wall TW, Nies AS, et al., editors. The pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press, 1990: 638–51

    Google Scholar 

  14. Hucker HB, Hoffman EA. Physiologic disposition and metabolic fate of indomethacin analogs I:1-p-chlorobenzylidenyl-5-methoxy-2-methylidene-3-acetic acid. J Pharm Sci 1971;60: 1049–52

    Article  PubMed  CAS  Google Scholar 

  15. Hadgraft J. Formulation of anti-inflammatory agents. In: Hensby C, Lowe NJ, editors. Nonsteroidal anti-inflammatory agents. Basel: Karger, 1989: 21–44

    Google Scholar 

  16. Singh P, Robert MS. Skin permeability and local tissue concentrations of nonsteroidal anti-inflammatory drags after topical application. J Pharm Exp Ther 1994; 268: 144–51

    CAS  Google Scholar 

  17. Payne-James JJ, Bray MJ, Kapadia S, et al. Topical nonsteroidal anti-inflammatory gel for the prevention of peripheral vein thrombophlebitis. Anaesthesia 1992; 47: 324–6

    Article  PubMed  CAS  Google Scholar 

  18. Friedman DI, Schwarz JS, Weisspar M. Submicron emulsion vehicle for enhanced transdermal delivery of steroidal and nonsteroidal antiinflammatory drugs. J Pharm Sci 1995; 84: 324–9

    Article  PubMed  CAS  Google Scholar 

  19. Willimann H, Walde P, Luisi PL, et al. Lecithin organogel as matrix for transdermal transport of drags. J Pharm Sci 1992; 81: 871–4

    Article  PubMed  CAS  Google Scholar 

  20. Singh P, Roberts MS. Dermal and underlying tissue pharmacokinetics of salicylic acid after topical application. J Pharmacokinet Biopharm 1993; 21: 337–73

    PubMed  CAS  Google Scholar 

  21. McNeill SC, Potts RO, Francoeur ML. Local enhanced topical delivery (LETD) of drugs: does it truly exist?. Pharm Res 1992; 9: 1422–7

    Article  PubMed  CAS  Google Scholar 

  22. Ishihama H, Kimata H, Mizushima Y. Percutaneous penetration of indomethacin. Experientia 1979; 35: 798–9

    Article  PubMed  CAS  Google Scholar 

  23. Rabinowitz RL, Feldman ES, Weinberger A, et al. Comparative tissue absorption of oral C-aspirin and topical triethanolamine C-salicylate in human and canine knee joints. J Clin Pharmacol 1982; 22: 42–8

    PubMed  CAS  Google Scholar 

  24. Wada Y, Etoh Y, Ohira A, et al. Percutaneous absorption and anti-inflammatory activity of indomethacin in ointment. J Pharm Pharmacol 1982; 34: 467–8

    Article  PubMed  CAS  Google Scholar 

  25. Davies NM, Anderson KE. Clinical pharmacokinetics of diclofenac. Clin Pharmacokinet 1997 Sep; 33: 184–213

    Article  PubMed  CAS  Google Scholar 

  26. Taburet AM, Singlas RC, Thomas F, et al. Pharmacokinetic comparison of oral and local action transcutaneous flurbiprofen in healthy volunteers. J Clin Pharm Ther 1995; 20: 101–7

    Article  PubMed  CAS  Google Scholar 

  27. Radermacher J, Jentsch D, Scholl MA, et al. Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease. Br J Clin Pharmacol 1991; 31: 537–41

    Article  PubMed  CAS  Google Scholar 

  28. Doogan DP. Topical non-steroidal anti-inflammatory drags. Lancet 1989; II: 1270–1

    Article  Google Scholar 

  29. Riess W, Schmid K, Botta L, et al. Percutaneous absorption of diclofenac. Arzneimittel Forschung 1986; 36: 1092–6

    PubMed  CAS  Google Scholar 

  30. Van den Ouweland FA, Eenhorn PC, Tan Y, et al. Transcutaneous absorption of naproxen gel. Eur J Clin Pharmacol 1989; 36: 209–11

    Article  PubMed  CAS  Google Scholar 

  31. Dawson M, McGee CM, Vine JH, et al. The disposition of biphenylacetic acid following topical application. Eur J Clin Pharmacol 1988; 33: 639–42

    Article  PubMed  CAS  Google Scholar 

  32. Dominkus M, Nicolakos M, Kotz R, et al. Comparison of tissue and plasma levels of ibuprofen after oral and topical administration. Arzneimittel Forschung 1996; 46: 1138–43

    PubMed  CAS  Google Scholar 

  33. Bauer H, Waldorf-Bolten E, Bolten W The pharmacokinetics, pharmacodynamics and comparative efficacy of flurbiprofen local action transcutaneous (LAT) [abstract]. Clin Rheumatol 1994; 13: 356

    Google Scholar 

  34. Frostick SP, Varley G, Smith C. The absorption of flurbiprofen from a topical preparation in patients undergoing an arthroscopy [abstract]. Clin Rheumatol 1994; 13: 356

    Google Scholar 

  35. Seth PL. Percutaneous absorption of ibuprofen from different formulations. Arzneimittel Forschung 1993; 43: 919–21

    PubMed  CAS  Google Scholar 

  36. Gallacchi G, Marcolongo R. Pharmacokinetics of diclofenac hydroxyethylpyrrolidine (DHEP) plasters in patients with monolateral knee joint effusion. Drugs Exp Clin Res 1993; 19: 95–7

    PubMed  CAS  Google Scholar 

  37. Grahame R. The NSAID patch. Eur J Rheumatol Inflamm 1994; 14: 1–2

    PubMed  CAS  Google Scholar 

  38. O’Callaghan CA, Andrews PA, Ogg CS. Renal disease and use of topical non-steroidal anti-inflammatory drugs. BMJ 1994; 308: 110–1

    Article  PubMed  Google Scholar 

  39. Grahame R. Transdermal non-steroidal anti-inflammatory agents. Br J Clin Pract 1996; 49: 33–5

    Google Scholar 

  40. Dreiser RL, Roche R, De Sahb R, et al. Flurbiprofen local action transcutaneous (LAT): clinical evaluation in the treatment of acute ankle sprains. Eur J Rheumatol Inflamm 1994; 14: 9–13

    PubMed  CAS  Google Scholar 

  41. Dreiser RL, Chariot J, Lopez A, et al. Clinical evaluation of niflumic acid gel in the treatment of uncomplicated ankle sprains. Curr Med Res Opin 1990; 12: 93–9

    Article  PubMed  CAS  Google Scholar 

  42. Campbell J, Dunn T. Evaluation of topical ibuprofen cream in the treatment of acute ankle sprains. J Accid Emerg Med 1994; 11: 178–82

    Article  PubMed  CAS  Google Scholar 

  43. Diebschlag W, Nocker W, Bullingham R. A double-blind study of the efficacy of ketorolac tromethamine gel in the treatment of ankle sprain, in comparison to placebo and etofenamate. J Clin Pharmacol 1990; 30: 82–9

    PubMed  CAS  Google Scholar 

  44. Schapira D, Linn S, Scharf Y A placebo-controlled evaluation of diclofenac diethylamine salt in the treatment of lateral epicondylitis of the elbow. Curr Ther Res 1991; 49: 162–8

    Google Scholar 

  45. Mattara L, Trotta F, Biasi D, et al. Evaluation of the efficacy and tolerability of a new locally acting preparation of flurbiprofen in scapulohumeral periarthritis. Eut J Rheumatol Inflamm 1994; 14: 15–20

    CAS  Google Scholar 

  46. Ginsberg F, Famaey JP. Double-blind, randomized crossover study of the percutaneous efficacy and tolerability of a topical indomethacin spray versus placebo in the treatment of tendinitis. J Int Med Res 1991; 19: 131–6

    PubMed  CAS  Google Scholar 

  47. Dreiser RL, Ditisheim A, Chariot J, et al. A double-blind, placebo controlled study of niflumic acid gel in the treatment of acute tendinitis. Eur J Rheumatol Inflamm 1991; 11: 38–45

    PubMed  CAS  Google Scholar 

  48. Poul J, West J, Buchanan N, et al. Local action transcutaneous flurbiprofen in the treatment of soft tissue rheumatism. Br J Rheumatol 1993; 32: 1000–3

    Article  PubMed  CAS  Google Scholar 

  49. McLatchie GR, McDonald M, Lawrence GF, et al. Soft tissue trauma: a randomised controlled trial of the topical application of felbinac, a new NSAID. Br J Clin Pract 1989; 44: 277–80

    Google Scholar 

  50. Russell AL. Piroxicam 0.5% topical gel compared to placebo in the treatment of acute soft tissue injuries: a double-blind trial comparing efficacy and safety. Clin Invest Med 1991; 14: 35–44

    PubMed  CAS  Google Scholar 

  51. Thorling J, Linden B, Berg R, et al. A double-blind comparison of naproxen gel and placebo in the treatment of soft tissue injuries. Curr Res Opin 1990; 12: 242–8

    Article  CAS  Google Scholar 

  52. Airaksinen O, Vernalainen J, Pietilainen T. Ketoprofen 2.5% gel vs placebo gel in the treatment of acute soft tissue injuries. Int J Clin Pharm Ther Toxicol 1993; 31: 561–3

    CAS  Google Scholar 

  53. Akermark C, Forsskahl B. Topical indomethacin in overuse injuries in athletes: a randomized double-blind study comparing Elmetacin with oral indomethacin and placebo. Int J Sports Med 1990; 11: 393–6

    Article  PubMed  CAS  Google Scholar 

  54. Grahame R, Mattara L, Aoki K, et al. A meta-analysis to compare flurbiprofen LAT to placebo in the treatment of soft tissue rheumatism [abstract]. Clin Rheumatol 1994; 13: 357

    Google Scholar 

  55. Moore RA, Tramer MR, Carroll D, et al. Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ 1998; 316: 333–8

    Article  PubMed  CAS  Google Scholar 

  56. Morrison W. A multicentre, randomised, double-blind, doubledummy trial to compare the use of topical Traxam gel with oral ibuprofen in the treatment of acute neck sprain: clinical trial report, Lederle Laboratories, 1993

  57. Dieppe PA. The topical NSAID felbinac versus oral ibuprofen: a comparison of efficacy in the treatment of mild to moderate osteoarthritis of the knee. Clinical trial report, Lederle Laboratories, 1993

  58. Tsuyama N, Kurokawa T, Nagano A, et al. Clinical evaluation of L-141 ointment of arthritis deformans of the knee. Clin Med 1985; 1: 697–729

    Google Scholar 

  59. Vanderstraeten G, Schuermans P. Study on the effect of etofenamate 10% cream in comparison with an oral NSAID in strains and sprains due to sports injuries. Med Phys 1990; 13: 139–41

    CAS  Google Scholar 

  60. Nash P, Smith M, Hazleman BL. Acute rotator cuff tendinitis: a comparison of subacromial injection of triamcinolone acetonide and topical 3% biphenyl acetic acid (BPAA) cream applied to the shoulder [abstract]. Br J Rheumatol 1988; 27: 10

    Google Scholar 

  61. Duteil L, Queille C, Poncet M, et al. Objective assessment of topical corticosteroids and non-steroidal anti-inflammatory drugs in methyl-nicotinate-induced skin inflammation. Clin Exp Dermatol 1990; 15: 195–9

    Article  PubMed  CAS  Google Scholar 

  62. Anon. Topical NSAIDs: a gimmick or a godsend? [editorial]. Lancet 1989; 2: 779–80

  63. Scott DL. Guidelines for the diagnosis, investigation and management of osteoarthritis of the hip and knee. J R Coll Physicians Lond 1993; 27: 391–6

    Google Scholar 

  64. Bouchier-Hayes TA, Rotman H, Darekar BS. Comparison of the efficacy and tolerability of diclofenac gel (Voltarol Emulgel) and felbinac gel (Traxam) in the treatment of soft tissue injuries. Br J Clin Pract 1990; 44: 319–20

    PubMed  CAS  Google Scholar 

  65. Ritchie LD. A clinical evaluation of flurbiprofen LAT and piroxicam gel: a multicenter study in general practice. Clin Rheumatol 1996; 15: 243–7

    Article  PubMed  CAS  Google Scholar 

  66. Zerbi E, Pace A, de Marchi F, et al. Ketoprofen lysine salt in a new foam formulation for the topical treatment of traumatic injuries: a controlled, between-patient, clinical trial. Curr Ther Res 1992; 51: 823–9

    Google Scholar 

  67. Dreiser RL, Tisne-Camus M. DHEP plasters as a topical treatment of knee osteoarthritis — a double-blind placebo-controlled study. Drugs Exp Clin Res 1993; 19: 121–7

    Google Scholar 

  68. Kageyama T. A double-blind placebo-controlled multicenter study of piroxicam 0.5% gel in osteoarthritis of the knee [abstract]. Eur J Rheumatol Inflamm 1987; 8: 114–5

    Google Scholar 

  69. Roth SH. A controlled clinical investigation of 3% diclofenac/ 2.5% sodium hyaluronate topical gel in the treatment of uncontrolled pain in chronic oral NSAID users with ostearthritis. Int J Tissue React 1995; 17: 129–32

    PubMed  CAS  Google Scholar 

  70. Shackel N, Day RO, Kellett B, et al. Copper-salicylate gel for pain relief in ostearthritis: a randomised controlled trial. Med J Aust 1997; 167: 134–6

    PubMed  CAS  Google Scholar 

  71. Algozzine GJ, Stein GH, Doering PL, et al. Trolamine salicylate cream in osteoarthritis of the knee. JAMA 1982; 247: 1311–3

    Article  PubMed  CAS  Google Scholar 

  72. Sandelin J, Harilainen A, Crone H, et al. Local NSAID gel (eltenac) in the treatment of osteoarthritis of the knee. Scand J Rheumatol 1997; 26: 287–92

    Article  PubMed  CAS  Google Scholar 

  73. Giacovazzo M. Clinical evaluation of a new NSAID applied topically (BPAA gel) vs. diclofenac emulgel in elderly osteoarthritis patients. Drugs Exp Clin Res 1992; 18: 201–3

    PubMed  CAS  Google Scholar 

  74. Arendt-Nielsen L, Drewes AM, Brennum J. Quantitative assessment of joint pain following treatment of rheumatoid arthritis with ibuprofen cream. Scand J Rheumatol 1994; 23: 334–7

    Article  PubMed  CAS  Google Scholar 

  75. De Benedittis G, Lorenzetti A. Topical aspirin/diethyl ether mixture versus indomethacin and diclofenac/diethyl ether mixtures for acute herpetic neuralgia and postherpetic neuralgia: a double-blind crossover placebo-controlled study. Pain 1996; 65: 48–53

    Google Scholar 

  76. Pigatto PD, Mozzanica N, Bigardi AS, et al. Topical NSAID allergic contact dermatitis Italian experience. Contact Derm 1993; 29: 39–41

    Article  PubMed  CAS  Google Scholar 

  77. Sitenga GL, Ing EB, Van Dellen RG, et al. Asthma caused by topical application of ketorolac. Ophthalmology 1996; 103: 890–2

    PubMed  CAS  Google Scholar 

  78. Fernando AHN, Thomas S, Temple RM, et al. Renal failure after topical use of NSAIDs [letter]. BMJ 1994; 308: 533

    Article  PubMed  CAS  Google Scholar 

  79. Newbery R, Shuttleworth P, Rapier C. A muticentre post marketing surveillance study to evaluate the safety and efficacy of felbinac 3% gel in the treatment of musculoskeletal disorders in general practice. Eur J Clin Res 1992; 3: 139–50

    Google Scholar 

  80. Hosie G, Bird H. The topical NSAID felbinac versus oral NSAIDs: a critical review. Eur J Rheumatol Inflamm 1994; 14: 21–8

    PubMed  CAS  Google Scholar 

  81. Muldoon C, Rees EJ. Safety and tolerability of flurbiprofen LAT [abstract]. Clin Rheumatol 1994; 13: 357

    Google Scholar 

  82. Evans JMM, McMahon AD, McGilchrist MM, et al. Topical non-steroidal anti-inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: a record linkage case-control study. BMJ 1995; 311: 22–7

    Article  PubMed  CAS  Google Scholar 

  83. Sharkawi MS. Clinical evaluation of Voltaren Emulgel in the treatment of localized rheumatic and traumatic painful conditions. Postgrad Doct 1990 May: 38–40

  84. Wynne HA, Campbell M. Pharmacoeconomics of nonsteroidal antiinflammatory drugs (NSAIDs). Pharmacoeconomics 1993; 3: 107–23

    Article  PubMed  CAS  Google Scholar 

  85. Peacock M, Rapier C. The topical NSAID felbinac is a costeffective alternative to oral NSAIDs for the treatment of rheumatic conditions. Br J Med Econ 1993; 6: 135–42

    Google Scholar 

  86. El-Hadidi T, El-Garf A. Double-blind study comparing the use of Voltaren Emulgel versus regular gel during ultrasonic sessions in the treatment of localized traumatic and rheumatic painful conditions. J Int Med Res 1991; 19: 219–7

    PubMed  CAS  Google Scholar 

  87. Benson HAE, McElnay JC. Topical non-steroidal anti-inflammatory products as ultrasound couplants: their potential in phonophoresis. Physiotherapy 1994; 80: 74–6

    Article  Google Scholar 

  88. Koay P. The emerging roles of topical non-steroidal anti-inflammatory agents in ophthalmology. Br J Ophthalmol 1996; 80: 480–5

    Article  PubMed  CAS  Google Scholar 

  89. O’Hanlon JJ, McCleane G, Muldoon T. Preoperative application of piroxicam gel compared to a local anaesthetic field block for postoperative analgesia. Acta Anaesth Scand 1996; 40: 715–8

    Article  PubMed  Google Scholar 

  90. Heasmann PA, Benn DK, Kelly PJ, et al. The use of topical flurbiprofen as an adjunct to non-surgical management of periodontal disease. J Clin Peridont 1993; 20: 457–64

    Article  Google Scholar 

  91. Jeffcoat MK, Reddy MS, Haigh S, et al. A comparison of topical ketorolac, systemic flurbiprofen, and placebo for the inhibition of bone loss in adult periodontitis. J Periodont 1995; 66: 329–38

    Article  PubMed  CAS  Google Scholar 

  92. Steen KH, Reeh PW, Kreysel HW. Dose-dependent competitive block by topical acetylsalicylic and salicylic acid of low-pH-induced cutaneous pain. Pain 1996; 64: 71–82

    Article  PubMed  CAS  Google Scholar 

  93. Moiniche S, Pedersen JL, Kehlet H. Topical ketorolac has no antinociceptive or anti-inflammatory effect in thermal injury. Burns 1994; 20: 483–6

    Article  PubMed  CAS  Google Scholar 

  94. Demling RH, Lalonde C. Topical ibuprofen decreases early postburn edema. Surgery 1987; 102: 857–61

    PubMed  CAS  Google Scholar 

  95. Sift-Carter R, Edner D, Brenner D, et al. Use of topical NSAIDs in patients receiving systemic NSAID treatment: a pharmacybased study in Germany. J Clin Epidemiol 1997; 50: 217–8

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jan H. Vaile.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vaile, J.H., Davis, P. Topical NSAIDs for Musculoskeletal Conditions. Drugs 56, 783–799 (1998). https://doi.org/10.2165/00003495-199856050-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199856050-00004

Keywords

Navigation